The arrival of cell-based therapies is a revolution in medicine. However, its safe clinical
application in a rational manner depends on reliable, clinically applicable methods for …

Cell-based therapies, such as adoptive immunotherapy and stem-cell therapy, have
received considerable attention as novel therapeutics in oncological research and clinical …

Background—Intracoronary transfer of autologous bone marrow cells (BMCs) promotes
recovery of left ventricular systolic function in patients with acute myocardial infarction …

Background—Recent results from animal studies suggest that stem cells may be able to
home to sites of myocardial injury to assist in tissue regeneration. However, the histological …

Myocardial regeneration using stem and progenitor cell transplantation in the injured heart
has recently become a major goal in the treatment of cardiac disease. Experimental studies …

Introduction Ischemic heart diseases, especially the myocardial infarction, is a major hazard
problem to human health. Despite substantial advances in control of risk factors and …

In regenerative medicine, clinical imaging is indispensable for characterizing damaged
tissue and for measuring the safety and efficacy of therapy. However, the ability to track the …

Cardiovascular disease is now the leading cause of adult death in the world. According to
new estimates from the World Health Organization, myocardial infarction (MI) is responsible …

Cell therapy is a promising therapeutic option for treating patients with ischemic diseases.
The efficiency of cell therapy to augment recovery after ischemia depends on the sufficient …

The versatility of pluripotent stem cells, attributable to their unlimited self-renewal capacity
and plasticity, has sparked a considerable interest for potential application in regenerative …